cas 58479-61-1||tert-butyl-chloro-diphenylsilane

Nom du produit:tert-butyl-chloro-diphenylsilane

IUPAC Name:tert-butyl(chloro)diphenylsilane

Unité d'emballage	Stock disponible	Prix($)
CM328470-500g	in stock	ȅƥȖ
CM328470-1000g	in stock	ŪȖŪ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 58479-61-1 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:58479-61-1; Formule moléculaire:C16H19ClSi; Point de fusion:-; Code SMILES:Cl[Si](C1=CC=CC=C1)(C(C)(C)C)C2=CC=CC=C2; Densité:

: Numéro de catalogue:CM328470; Poids moléculaire:274.86; Point d'ébullition:; N° Mdl:; Stockage:

: Namodenoson; Namodenoson is a small orally bioavailable drug that binds with high affinity and selectivity to the A3 adenosine receptor (A3AR). Namodenoson was evaluated in Phase II trials for two indications, as a second line treatment for hepatocellular carcinoma, and as a treatment for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
Namodenoson granted Orphan Drug and Fast track status from the FDA. A3AR is highly expressed in diseased cells whereas low expression is found in normal cells. This differential effect accounts for the excellent safety profile of the drug.